Evaluating non-randomised intervention studies - NIHR Health ...

More documents

Recommendations

Info

Health Technology Assessment ProgrammeMembersDiagnostic Technologies & Screening PanelChair,Dr Ron Zimmern, Director ofthe Public Health Genetics Unit,Strangeways ResearchLaboratories, CambridgeDr Paul Cockcroft, ConsultantMedical Microbiologist/Laboratory Director, PublicHealth Laboratory,St Mary’s Hospital,PortsmouthProfessor Adrian K Dixon,Professor of Radiology,Addenbrooke’s Hospital,CambridgeDr David Elliman, Consultant inCommunity Child Health,LondonDr Andrew Farmer, SeniorLecturer in General Practice,Institute of Health Sciences,University of OxfordDr Karen N Foster, ClinicalLecturer, Dept of GeneralPractice & Primary Care,University of AberdeenProfessor Jane Franklyn,Professor of Medicine,University of BirminghamProfessor Antony J Franks,Deputy Medical Director, TheLeeds Teaching Hospitals NHSTrustMr Tam Fry, HonoraryChairman, Child GrowthFoundation, LondonDr Susanne M Ludgate, MedicalDirector, Medical DevicesAgency, LondonDr William Rosenberg, SeniorLecturer and Consultant inMedicine, University ofSouthamptonDr Susan Schonfield, CPHMSpecialised ServicesCommissioning, CroydonPrimary Care TrustDr Margaret Somerville,Director of Public Health,Teignbridge Primary Care Trust,DevonMr Tony Tester, Chief Officer,South Bedfordshire CommunityHealth Council, LutonDr Andrew Walker, SeniorLecturer in Health Economics,University of GlasgowProfessor Martin J Whittle,Head of Division ofReproductive & Child Health,University of BirminghamDr Dennis Wright, ConsultantBiochemist & Clinical Director,Pathology & The KennedyGalton Centre, Northwick Park& St Mark’s Hospitals, HarrowMembersPharmaceuticals PanelChair,Dr John Reynolds, ClinicalDirector, Acute GeneralMedicine SDU, OxfordRadcliffe HospitalProfessor Tony Avery, Professorof Primary Health Care,University of NottinghamProfessor Iain T Cameron,Professor of Obstetrics &Gynaecology, University ofSouthamptonMr Peter Cardy, ChiefExecutive, Macmillan CancerRelief, LondonDr Christopher Cates, GP andCochrane Editor, Bushey HealthCentre, Bushey, Herts.Mr Charles Dobson, SpecialProjects Adviser, Department ofHealthDr Robin Ferner, ConsultantPhysician and Director, WestMidlands Centre for AdverseDrug Reactions, City HospitalNHS Trust, BirminghamDr Karen A Fitzgerald,Pharmaceutical Adviser, Bro TafHealth Authority, CardiffProfessor Alastair Gray,Professor of Health Economics,Institute of Health Sciences,University of OxfordMrs Sharon Hart, ManagingEditor, Drug & TherapeuticsBulletin, LondonDr Christine Hine, Consultant inPublic Health Medicine,Bristol South & West PrimaryCare TrustProfessor Robert Peveler,Professor of Liaison Psychiatry,Royal South Hants Hospital,SouthamptonDr Frances Rotblat, CPMPDelegate, Medicines ControlAgency, LondonMrs Katrina Simister, NewProducts Manager, NationalPrescribing Centre, LiverpoolDr Ken Stein, Senior Lecturer inPublic Health, University ofExeterProfessor Terence Stephenson,Professor of Child Health,University of NottinghamDr Richard Tiner, MedicalDirector, Association of theBritish Pharmaceutical Industry,LondonProfessor Dame Jenifer Wilson-Barnett, Head of FlorenceNightingale School of Nursing& Midwifery, King’s College,London184Current and past membership details of all HTA ‘committees’ are available from the HTA website (www.ncchta.org)
Health Technology Assessment 2003; Vol. 7: No. 27MembersTherapeutic Procedures PanelChair,Professor Bruce Campbell,Consultant Vascular andGeneral Surgeon, Royal Devon& Exeter HospitalDr Mahmood Adil, Head ofClinical Support & HealthProtection, Directorate ofHealth and Social Care (North),Department of Health,ManchesterProfessor John Bond, Head ofCentre for Health ServicesResearch, University ofNewcastle upon TyneMr Michael Clancy, Consultantin A & E Medicine,Southampton General HospitalDr Carl E Counsell, SeniorLecturer in Neurology,University of AberdeenDr Keith Dodd, ConsultantPaediatrician, DerbyshireChildren’s Hospital, DerbyProfessor Gene Feder, Professorof Primary Care R&D, Barts &the London, Queen Mary’sSchool of Medicine andDentistry, University of LondonMs Bec Hanley, FreelanceConsumer Advocate,Hurstpierpoint, West SussexProfessor Alan Horwich,Director of Clinical R&D, TheInstitute of Cancer Research,LondonDr Phillip Leech, PrincipalMedical Officer for PrimaryCare, Department of Health,LondonMr George Levvy, ChiefExecutive, Motor NeuroneDisease Association,NorthamptonProfessor James Lindesay,Professor of Psychiatry for theElderly, University of LeicesterDr Mike McGovern, SeniorMedical Officer, Heart Team,Department of Health, LondonDr John C Pounsford,Consultant Physician, NorthBristol NHS TrustProfessor Mark Sculpher,Professor of Health Economics,Institute for Research in theSocial Services, University ofYorkDr L David Smith, ConsultantCardiologist, Royal Devon &Exeter HospitalProfessor Norman Waugh,Professor of Public Health,University of AberdeenCurrent and past membership details of all HTA ‘committees’ are available from the HTA website (www.ncchta.org)185
Page 1 and 2:
Health Technology Assessment 2003;
Page 3 and 4:
Evaluating non-randomisedinterventi
Page 5 and 6:
Page 7:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17:
Page 21 and 22:
Page 23 and 24:
© Queen’s Printer and Controller
Page 25 and 26:
Page 27 and 28:
© Queen’s Printer and Controller
Page 29 and 30:
Page 31 and 32:
Page 33:
Page 36 and 37:
Evaluation of checklists and scales
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
32TABLE 8 Details of top 60 quality
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
38TABLE 10 Other domains: reporting
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Use of quality assessment in system
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Empirical estimates of bias associa
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Empirical evaluation of the ability
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
70TABLE 22 Comparison of concurrent
Page 84 and 85:
Page 86 and 87:
74TABLE 26 Comparison of methods of
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
80TABLE 33 Hypothetical example dem
Page 94 and 95:
82TABLE 34 Hypothetical example dem
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Discussion and conclusions88histori
Page 102 and 103:
Discussion and conclusions90For exa
Page 104 and 105:
Discussion and conclusionsNon-rando
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121:
Page 124 and 125:
Appendix 1data)) or (non-random$ or
Page 126 and 127:
Appendix 2AuthorYearENDARESourcePub
Page 128 and 129:
Appendix 2Author:Accession No:Endno
Page 130 and 131:
Appendix 20 0 00Additional outcomes
Page 132 and 133:
Appendix 2Endnote NoWas CMA conside
Page 134 and 135:
122AuthorOrigin aModified toolTool
Page 136 and 137:
124AuthorOrigin aModified toolTool
Page 138 and 139: 126AuthorOrigin aModified toolTool
Page 148 and 149: Appendix 4136DuRant, 1994 99The typ
Page 151 and 152: Health Technology Assessment 2003;
Page 155 and 156: © Queen’s Printer and Controller
Page 185: Health Technology Assessment 2003;
Page 190: Health Technology Assessment Progra
show all

Evaluating non-randomised intervention studies - NIHR Health ...

Create successful ePaper yourself

Delete template?

Save as template?